In theory, CH associated with other syndromic disorders (e.g. Pendred syndrome, FOXE1, PAX8, NKX2-1, GLIS3, JAG1, NKX2-5, and GNAS) could allow for prenatal screening to identify recurrence. This evidence concerns the gene NKX2-5 and cyclic hematopoiesis.